SCAP-Nerve Protocol for Spinal Cord Plasticity
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new treatment approach called the SCAP-Nerve protocol, which aims to improve hand movement and dexterity. By pairing gentle electrical stimulation of the brain and a nerve in the arm, researchers aim to encourage the spinal cord to adapt and enhance motor function. The trial seeks typically developing adults without neurological or musculoskeletal issues in their arms or hands, who are willing to attend up to four sessions. The results could eventually benefit those with spinal cord injuries or cerebral palsy. As an unphased trial, participants have a unique opportunity to contribute to groundbreaking research that could lead to significant advancements in treatment options.
Do I have to stop taking my current medications for the trial?
The trial requires that you do not use medications that lower the seizure threshold. If you are taking such medications, you may need to stop them to participate.
What prior data suggests that the SCAP-Nerve protocol is safe for inducing spinal cord plasticity?
Research has shown that the SCAP-Nerve protocol, which uses brain and spinal cord stimulation, is under evaluation for safety and its potential to improve hand and arm movement. Studies have found that noninvasive methods like this typically have manageable side effects. The protocol employs gentle electrical signals to enhance communication between the spinal cord and brain, aiding recovery with minimal discomfort.
Researchers are studying the protocol to ensure the stimulation is safe and effective. Early results are promising, with no serious side effects reported in similar studies. However, since this study is in its early stages and involves healthy adults, monitoring for any side effects is crucial before broader application.12345Why are researchers excited about this trial?
Researchers are excited about the SCAP-Nerve Protocol because it aims to enhance spinal cord plasticity using a novel combination of paired motor cortical and median nerve stimulation. Unlike traditional treatments that often focus on medication or physical therapy to manage symptoms, this protocol targets the spinal cord directly to potentially restore function through precise timing of nerve stimulations. By synchronizing these stimulations, the protocol hopes to promote more effective neural connections, offering a new avenue for improving mobility and recovery in patients.
What evidence suggests that the SCAP-Nerve protocol could be effective for promoting spinal cord plasticity?
This trial will compare different stimulation methods to assess their impact on movement abilities. Research has shown that combining brain and nerve stimulation, as in the SCAP-Nerve method, can enhance movement abilities. Participants in the SCAP arm will receive paired motor cortical and median nerve stimulation, timed to converge in the spinal cord. Early results suggest that when these stimulations meet in the spinal cord rather than the brain, they lead to stronger arm movements. This method relies on "plasticity," meaning the spinal cord can change and improve over time. Previous studies have demonstrated that similar techniques can significantly enhance motor skills by promoting this adaptability. This approach could address movement issues, potentially benefiting individuals with spinal cord injuries or cerebral palsy.678910
Who Is on the Research Team?
Jason Carmel, MD, PhD
Principal Investigator
Columbia University
Are You a Good Fit for This Trial?
This trial is for healthy adults with no neurological or musculoskeletal problems in their arms or hands, who are willing to attend up to 4 sessions and keep their caffeine and exercise habits the same during the study.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 90 trials of paired motor cortical and median nerve stimulation for 15 minutes at sub-threshold intensities, timed to converge in the cervical spinal cord
Follow-up
Participants are monitored for physiological and behavioral effects of the SCAP protocol
What Are the Treatments Tested in This Trial?
Interventions
- SCAP-Nerve protocol
Trial Overview
Researchers are testing a new paired stimulation technique (SCAP-Nerve protocol) that combines mild brain and nerve stimulation using devices like Digitimer DS8R and MagPro X100. The goal is to see if this method can improve hand movement by targeting the cervical spinal cord.
How Is the Trial Designed?
4
Treatment groups
Experimental Treatment
Active Control
With this session, participants will receive 90 trials of 0.1hz paired motor cortical stimulation and median nerve stimulation for 15 minutes at sub-threshold intensities, timed to converge in the cervical spinal cord simultaneously.
With this session, participants will receive 90 trials of 0.1hz median nerve stimulation for 15 minutes at sub-threshold intensities.
With this session, participants will receive 90 trials of 0.1hz motor cortical stimulation for 15 minutes at sub-threshold intensities.
With this session, participants will receive 90 trials of 0.1hz paired motor cortical stimulation and median nerve stimulation for 15 minutes at sub-threshold intensities, timed to be 40 milliseconds apart in the cervical spinal cord.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Columbia University
Lead Sponsor
Citations
Real-World Outcomes of Spinal Cord Stimulation - PMC
Among the 505 patients who underwent SCS trials, the overall trial success rate was 86.1%, with 435 patients experiencing at least 50% pain ...
Spinal Cord Stimulation Real-World Outcomes: A 24-Month ...
Conclusions: In this real-world cohort, SCS therapy results in sustained, clinically significant improvements in pain, neuropathic symptoms, and ...
Spinal Cord Stimulation vs Medical Management for ...
Results showed that patients treated with either conventional or novel SCS had better functionality than patients treated with CMM, with ...
4.
medschool.cuanschutz.edu
medschool.cuanschutz.edu/graduate-medical-education/newsroom/graduate-medical-education/spinal-cord-stimulation-for-pain-management-following-spinal-cord-injury--a-systematic-reviewSpinal Cord Stimulation for Pain Management Following ...
In our review, all included studies demonstrated some degree of pain improvement following SCS, with 8 studies reporting a ≥30% improvement in pain; a commonly ...
A systematic review of evidence comparing spinal cord ...
The primary outcome was ≥50% pain reduction in low back pain at 6 months. In the SCS group, 14% (95% CI: 7–20%) vs. 5% (95% CI: 1–9%) in ...
6.
ninds.nih.gov
ninds.nih.gov/health-information/clinical-trials/spinal-cord-associative-plasticity-studySpinal Cord Associative Plasticity Study
Spinal cord associative plasticity (SCAP) is a combined cortical and spinal electrical stimulation technique developed to induce recovery of arm and hand ...
7.
binausa.org
binausa.org/research-clinical-trials/motor/individual-trial/spinal-cord-associative-plasticity-study-scap/Spinal Cord Associative Plasticity Study (SCAP) - BINA
This study seeks to improve arm and hand function in individuals with spinal cord injury. Noninvasive stimulation to both the brain and spinal cord.
Cervical Spinal Cord Associative Plasticity
This N/A medical study run by Columbia University is evaluating whether SCAP-Nerve protocol will have tolerable side effects & efficacy for ...
Spinal Cord Associative Plasticity (SCAP)
We are testing different combinations of magnetic and electrical brain and spinal cord stimulation to see if we can improve hand function by activating spared ...
Cervical Spinal Cord Associative Plasticity
This study will first be conducted in typically developing adults to confirm the cervical spinal cord as the ideal target and verify the present ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.